Mereo BioPharma Group plc 10-K for FY2024
Mereo BioPharma Group plc (MREO)
10-K
2025-03-26
For: 2024-12-31
View Original
Added on
April 08, 2026
About this 10-K
Mereo BioPharma Group plc filed this 10-K on March 26, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $10M a year earlier
- Net loss
- $43.25M
- compared with a net loss of $29.47M a year earlier
- Diluted EPS
- -$0.06
- compared with -$0.04 a year earlier